Approved Study Database

Ref. No. Scientific Title Principal investigator
2005.207 Analgesic Efficacy and Pharmacokinetic of Ropivacaine Continuous Wound Instillation Following Hepatic Resection Dr. Chan K.C. Simon
2005.197 An Open-Label Multicenter Randomized Phase 3 Study Comparing the Combination of DOXIL_/CAELYX_ and YONDELIS Prof. Yeo Winnie
2005.196 An Expanded Access Program of Tarceva (Erlotinib) in Patients with Advanced Stage IIIB/IV Non-Small Cell Lung Cancer Prof. Mok S.K. Tony
2005.192 The Efficacy of Imipramine in Treatment of Functional Dyspepsia: A Double Blind Randomized Placebo Controlled Trial Dr. Wu Che Yuen Justin
2005.189 Randomized, Open-Label, Comparative Study To Evaluate Early Viral Load Reductions and Exploratory Viral Kinetics Following Administration of Entecavir or Adefovir in Nucleoside-Na_ve Adults with Chronic Hepatitis B Infection Dr. Leung Wai Yee Nancy
2005.186 A Prospective Randomized Comparison of A Novel Hemostatic Clip (Resolution Clip Dr. Wu Che Yuen Justin
2005.184 Effect of High Dose Intravenous and Oral Pantoprazole in Preventioin of Recurrent Bleeding from Peptic Ulcers after Endoscopic Therapy Prof. Sung J.Y. Joseph
2005.180 A Pilot Study of Formula Pinggan in the Treatment of Liver Cirrhosis Prof. Sung J.Y. Joseph
2005.166 A Twelve-week, Randomized, Double-blind, Parallel-group, Multicenter, Dose Escalation Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination with Atenolol in Patients with Essential Hypertension Prof. Yu Cheuk Man
2005.157 Endoluminal Implantation of Enteryx_ for the Treatment of Gastro-Esophageal Reflux Disease Prof. Chiu Wai Yan Philip
2005.156 Clinical Bioequivalence Study on Two Allopurinol Formulations Prof. Yin Qiping Ophelia
2005.155 Clinical Bioequivalence Study on Two Gliclazide Formulations Prof. Chow S.S. Mossess
2005.153 A double-blind randomized comparison of celecoxib plus esomeprazole versus naproxen plus esomeprazole for prevention of recurrent ulcer bleeding in patients with arthritis and cardiothrombotic diseases (NSAID#8 Study) Prof. CHAN Francis K. L.
2005.151 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 to Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Glimepiride Alone or in Combination with Metformin Dr. So Wing Yee
2005.149 A One-Year, Open-Label, Single Arm, Multi-Center Trial Evaluating the Efficacy and Safety of Oral ICL670 (20mg/kg/day) in Patients Diagnosed with Transfusion-dependent Iron Overload Dr. Li Chi Kong
2005.148 Phase I Study on the Safety and Pharmacokinetics of IMD-1041 in Healthy Male Volunteers Prof. Brian Tomlinson
2005.146 A Randomised, Double-Blind, Placebo-Controlled Study of Cilostazol 100mg Twice Daily in the Treatment of Diabetic Nephropathy in Hong Kong Chinese Prof. Tong Chun Yip Peter
2005.142 Phase II Trial of PS-341 in Patients with Hepatocellular Carcinoma Prof. Mok S.K. Tony
2005.140 Capsule Endoscopy or Mesenteric Angiogram in Patients with Overt Gastrointestinal Bleeding of Obscure Origin: A Randomized Study Prof. Leung W.K.
2005.139 A 12-week, Double-Blind, Randomized Study to Investigate the Effect of 500_g Roflumilast Tablets Once Daily Versus Placebo on Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease Prof. Hui Shu Cheong David
2005.138 International Diabetes Management Practices Study, The Prof. Chan C.N. Juliana
2005.137 Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Dr. Ng Chi Fai
2005.136 A Single Arm Phase IV Study to Assess Efficacy and Safety of Bevacizumab in Combination With Irinotecan and Infusional 5 Prof. Chan T.C. Anthony
2005.133 Follow-Up Serial Infusions of Natrecor_ (Nesiritide) for the Management of Patients with Heart Failure Prof. Yu Cheuk Man
2005.123 Cardiovascular-Protective Effects of Herbal Medicine Danshen-Gegen. A Novel Randomized Double-Blind Placebo-Control Clinical Trial in High-Risk Hypertensive Subjects Prof. Chan Yan Keung Thomas
2005.121 Optimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies ptimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies Prof. Brian Tomlinson
2005.120 Comparison of Lercanidipine with Nifedipine Slow Release in Essential Hypertension Prof. Brian Tomlinson
2005.117 A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation Dr. Ng Chi Fai
2005.115 Effects of Growth Hormone on Body Fat Distribution, Insulin Action and Cardiovascular Risk Factors in Middle-aged Men with Metabolic Syndrome Prof. Kong PS Alice
2005.114 A Pilot Study of Enhanced External Counterpulsation for Cerebral Blood Flow Augmentation in Chinese Ischemic Stroke Patients with MCA Stenosis EASY-II Prof. Wong Ka Sing Lawrence
2005.111 Prediction of Blood Pressure Response to Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker by Phenotypic and Genotypic Determinants in Chinese Patients with Type 2 Diabetes, Borderline Hypertension and Microalbuminuria Prof. Brian Tomlinson
2005.110 A Randomized, Double-blind, Two-arms Placebo-controlled, Parallel-group, Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Atherogenic Dyslipidemia in Abdoninally Obese Patients Prof. Brian Tomlinson
2005.109 An Open Label Trial of Telbivudine (LdT) in Adults with Chronic Hepatitis B Previously Treated in Idenix-Sponsored Telbivudine Studies Dr. Leung WY Nancy
2005.108 A Multi-centre, Double-blinded, Randomized, Placebo-Controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome Prof. Hui David
2005.103 Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven_/Niastase_) in Acute Intracerebral Haemorrhage (Trial Phase: 3a) Prof. Wong Ka Sing Lawrence
2005.095 A Randomized, Open-labeled, Parallel, Comparative Study of the Efficacy and Tolerability of Rosuvastatin in LDL-C Reduction Using Different Dosing Regimes of 5mg Daily, 10mg Daily and 10mg Alternate day in Hong Kong Chinese Type 2 Diabetic Patients Dr. Chow Chun Chung Francis
2005.093 A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase II Study to Evaluate the Safety and Efficacy of Oral Dosing with GW679769 (50mg or 150mg) for Three Consecutive Days When Administered with a Single Intravenous Dose of Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting and Post-discharge Nausea and Vomiting in Female Subjects with Known Risk Factors for Post-operative Nausea and Vomiting Who are Undergoing Laparoscopic/Laparotomic Surgical Procedures Associated with an Increased Emetogenic Risk Prof. Gin Tony
2005.087 A Comparative Study of Visual Function Using the AcrySof Natural and the Acrysof SA 60 Intraocular Lens (IOLs) Prof. Lam S.C. Dennis
2005.084 Clinical Study to Test the Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients with IBS Prof. Sung J.Y. Joseph
2005.068 A Six-Month Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (with Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 Prof. Lam S.C. Dennis
2005.067 Combined Sphincterotomy and ballon dilation (ESBD) Versus Standard Sphincterotomy (ES) in Removing Biliary Stones - A Randomized Controlled Trial Dr. Cheung Ka Yin Frances
2005.063 A 26 Week, Double-blind, Randomized, Multicenter, Parallel Group, Active-controlled Study Comparing Aliskiren to Ramipril with Optional Addition of Hydrochlorothiazide, Followed by a 4 Week Double-blind, Randomized, Placebo-Controlled Withdrawal in Patients with Essential Hypertension Prof. Yu Cheuk Man
2005.058 A Pilot Study On the Use of A Novel Endoscopic Suturing Device [Eagle Claw_] in Patients with Massive Ulcer Bleeding Dr. Lau Y.W. James
2005.051 Prospective Randomized Study to Determine the Safety, Efficacy and Patients Dr. Chong K.L. Kelvin
2005.048 Treatment with Peginterferon Alfa-2a (40 KD) (PEGASYS_) of Chronic Hepatitis B Patients, Who Have Failed Anti-Viral Treatment Prof. Chan Lik Yuen Henry
2005.044 Comparison of Lidocaine 2% Gel Versus 1% Amethocaine Eyedrops for Primary Pterygium Dr. Leung YS Gloria
2005.035 Atypical Antipsychotics and Metabolic Outcomes in Chinese Patients: A Comparison of Olanzapine and Risperidone Dr. Leung Chi Ming
2005.034 Evaluation of the Combination Effect of A Bioengineered Skin Substitute and An Oral Aloe Vera for the Treatment of Chronic Diabetic Foot Ulcers in A Prospective, Randomized, Double-Blind Clinical Trial Prof. Liew Choong Tsek
2005.028 A Randomized, Blinded, Phase IIb Trial of Telbivudine (LdT) versus the Combination of Telbivudine and Valtorcitabine (Val-LdC) in Patients with Chronic Hepatitis B Prof. Chan Lik Yuen Henry
2005.022 A 24-week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Metformin or Metformin Combined with Fenofibrate) Study to Evaluate the Lipid Metabolic Effects, Safety and Tolerability of Tesaglitazar Therapy in Patients with Type 2 Diabetes and Low HDL-Cholesterol on a Fixed Background Therapy with a Statin Prof. Kong PS Alice

Page 245 of 254.